Skip to main content
Clinical Trials/NCT02436551
NCT02436551CompletedNot Applicable

Gestational Diabetes in Central Asia: Prevalence and Management

Ludwig-Maximilians - University of Munich1 site in 1 country3,200 target enrollmentStarted: September 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
3,200
Locations
1
Primary Endpoint
prevalence of gestational diabetes

Study Overview

Brief Summary

Evaluate prevalence and management of gestational diabetes in Tajikistan in two different settings (one rural and one urban).

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • pregnancy

Exclusion Criteria

  • known diabetes mellitus

Outcomes

Primary Outcomes

prevalence of gestational diabetes

Time Frame: 1 year

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Klaus Parhofer

Professor of Endocrinology and Metabolism

Ludwig-Maximilians - University of Munich

Study Sites (1)

Loading locations...

Similar Trials